2023 Vol.41, N°7 - Table of contents
July 2023
One year in review
CER16836
2023,41,7
Pg. 1377-1383
Free to view
Osteoporosis and gut microbiota, radiofrequency echographic multispectrometry and machine learning: one year in review 2023
M. Maffi, G. De Mattia, M. Mazzantini
DOI: https://doi.org/10.55563/clinexprheumatol/ma4l1t
M. Maffi, G. De Mattia, M. Mazzantini
DOI: https://doi.org/10.55563/clinexprheumatol/ma4l1t
Full Papers
CER15849
2023,41,7
Pg. 1384-1395
Compound 78c exerts a therapeutic effect on collagen-induced arthritis and rheumatoid arthritis
X. Zhang, H. Wang, X. Song, Y. Song, G. He, K. Fang, X. Chang
DOI: https://doi.org/10.55563/clinexprheumatol/0dck3t
X. Zhang, H. Wang, X. Song, Y. Song, G. He, K. Fang, X. Chang
DOI: https://doi.org/10.55563/clinexprheumatol/0dck3t
CER15910
2023,41,7
Pg. 1396-1408
Are SMAD2/4/7 genetic variants associated with rheumatoid arthritis susceptibility and severity?
A. Wajda, B. Stypińska, M. Czarnecka, D. Hasan, M. Jarończyk, E. Haładyj, K. Romanowska-Próchnicka, M. Olesińska, A. Pawlik, A. Paradowska-Gorycka
DOI: https://doi.org/10.55563/clinexprheumatol/oqu492
A. Wajda, B. Stypińska, M. Czarnecka, D. Hasan, M. Jarończyk, E. Haładyj, K. Romanowska-Próchnicka, M. Olesińska, A. Pawlik, A. Paradowska-Gorycka
DOI: https://doi.org/10.55563/clinexprheumatol/oqu492
CER15678
2023,41,7
Pg. 1409-1416
Increased risk of hospital admissions in patients with active systemic lupus erythematosus (SLE) classified according to two different SLE disease activity indices: a prospective cohort study
M.-C. Lu, C.-W. Hsu, M. Koo, N.-S. Lai
DOI: https://doi.org/10.55563/clinexprheumatol/2z3tyc
M.-C. Lu, C.-W. Hsu, M. Koo, N.-S. Lai
DOI: https://doi.org/10.55563/clinexprheumatol/2z3tyc
CER15984
2023,41,7
Pg. 1417-1426
Free to view
Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study
S. Hilliquin, J. Herrou, L. Gutermann, C. Goulvestre, J. Avouac, J. Henry, P. Hilliquin, M. Dougados, A. Moltó
DOI: https://doi.org/10.55563/clinexprheumatol/1h6h71
S. Hilliquin, J. Herrou, L. Gutermann, C. Goulvestre, J. Avouac, J. Henry, P. Hilliquin, M. Dougados, A. Moltó
DOI: https://doi.org/10.55563/clinexprheumatol/1h6h71
CER16031
2023,41,7
Pg. 1427-1433
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study
G.D. Sanna, M. Piga, A. Piga, O. Falco, E. Ponti, A. Cauli, A. Floris, A.A. Mangoni, G. Casu, G. De Luca, G.L. Erre
Collaborator/s: M.L. Cadoni, I. Cangemi, M. Dessì, A.L. Fedele, G. Ferraccioli, E. Gremese, N. Mundula, M. Piras
on behalf of the EDRA Study Group
DOI: https://doi.org/10.55563/clinexprheumatol/d9l4lt
G.D. Sanna, M. Piga, A. Piga, O. Falco, E. Ponti, A. Cauli, A. Floris, A.A. Mangoni, G. Casu, G. De Luca, G.L. Erre
Collaborator/s: M.L. Cadoni, I. Cangemi, M. Dessì, A.L. Fedele, G. Ferraccioli, E. Gremese, N. Mundula, M. Piras
on behalf of the EDRA Study Group
DOI: https://doi.org/10.55563/clinexprheumatol/d9l4lt
CER15862
2023,41,7
Pg. 1434-1442
Free to view
Aromatase mutation in men as a rare cause of osteoporosis: a case report and review of the literature
N.A. Stumper, H. Wientgen, L. Al-Hashimi, H.-W. Müller, S. Ohrndorf, T. Gaber, H. Siggelkow, P. Hoff
DOI: https://doi.org/10.55563/clinexprheumatol/gj7xal
N.A. Stumper, H. Wientgen, L. Al-Hashimi, H.-W. Müller, S. Ohrndorf, T. Gaber, H. Siggelkow, P. Hoff
DOI: https://doi.org/10.55563/clinexprheumatol/gj7xal
CER16040
2023,41,7
Pg. 1443-1450
Free to view
Prevalence of frailty and pre-frailty in patients with rheumatoid arthritis: a systematic literature review and meta-analysis
S. Germonpré, S. Mulier, L. Falzon, A. Boonen, M. Van Onna
DOI: https://doi.org/10.55563/clinexprheumatol/1kr7bs
S. Germonpré, S. Mulier, L. Falzon, A. Boonen, M. Van Onna
DOI: https://doi.org/10.55563/clinexprheumatol/1kr7bs
CER16094
2023,41,7
Pg. 1451-1455
Free to view
Differences in the strength of inhibition of interleukin-6 signalling by subcutaneous sarilumab and tocilizumab in rheumatoid arthritis patients
S. Saito, K. Suzuki, K. Yoshimoto, Y. Kondo, J. Kikuchi, H. Hanaoka, Y. Kaneko, T. Takeuchi
DOI: https://doi.org/10.55563/clinexprheumatol/k0ctlf
S. Saito, K. Suzuki, K. Yoshimoto, Y. Kondo, J. Kikuchi, H. Hanaoka, Y. Kaneko, T. Takeuchi
DOI: https://doi.org/10.55563/clinexprheumatol/k0ctlf
CER16141
2023,41,7
Pg. 1456-1462
Free to view
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study
C. Casadepax-Soulet, K. Benali, B. Crestani, E. Piekarski, B. Mahida, E. Ebstein, P.-A. Juge, M. Forien, P. Dieudé, S. Ottaviani
DOI: https://doi.org/10.55563/clinexprheumatol/kqyki5
C. Casadepax-Soulet, K. Benali, B. Crestani, E. Piekarski, B. Mahida, E. Ebstein, P.-A. Juge, M. Forien, P. Dieudé, S. Ottaviani
DOI: https://doi.org/10.55563/clinexprheumatol/kqyki5
CER15974
2023,41,7
Pg. 1463-1472
Free to view
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study
F. Behrens, G.-R. Burmester, M.W. Hofmann, M. Aringer, H. Kellner, A. Liebhaber, S. Wassenberg, M.A. Peters, M. Zortel, C. Amberger
DOI: https://doi.org/10.55563/clinexprheumatol/hlmsao
F. Behrens, G.-R. Burmester, M.W. Hofmann, M. Aringer, H. Kellner, A. Liebhaber, S. Wassenberg, M.A. Peters, M. Zortel, C. Amberger
DOI: https://doi.org/10.55563/clinexprheumatol/hlmsao
CER15848
2023,41,7
Pg. 1473-1479
Synovial fluid survivin and NETs as independent biomarkers in rheumatoid arthritis
F.F. De Souza, A.H. Schneider, C.C. Machado, S.C. De Almeida, T.A. Da Silva, F.Q. Cunha, P. Louzada-Junior, R.D. De Oliveira
DOI: https://doi.org/10.55563/clinexprheumatol/flzpgb
F.F. De Souza, A.H. Schneider, C.C. Machado, S.C. De Almeida, T.A. Da Silva, F.Q. Cunha, P. Louzada-Junior, R.D. De Oliveira
DOI: https://doi.org/10.55563/clinexprheumatol/flzpgb
CER15885
2023,41,7
Pg. 1480-1490
SERPINA1 and plasminogen as novel biomarkers in obstetric antiphospholipid syndrome patients
Z. Xie, J. Zhao, Y. Song, Y. Long, C. Huang, X. Liu, X. Tian, M. Li, J. Liu, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/n4s2ya
Z. Xie, J. Zhao, Y. Song, Y. Long, C. Huang, X. Liu, X. Tian, M. Li, J. Liu, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/n4s2ya
CER16162
2023,41,7
Pg. 1491-1499
Free to view
Risk of cancer, tuberculosis and serious infections in patients with ankylosing spondylitis, psoriatic arthritis and psoriasis treated with IL-17 and TNF-α inhibitors: a nationwide nested case-control analysis
H.W. Kim, E.H. Kim, M. Lee, I. Jung, S.S. Ahn
DOI: https://doi.org/10.55563/clinexprheumatol/qkiorp
H.W. Kim, E.H. Kim, M. Lee, I. Jung, S.S. Ahn
DOI: https://doi.org/10.55563/clinexprheumatol/qkiorp
CER16097
2023,41,7
Pg. 1500-1506
Free to view
Deep remission within 12 months prevents renal flare and damage accrual in lupus nephritis
J. Kikuchi, H. Hanaoka, S. Saito, T. Oshige, K. Hiramoto, T. Takeuchi, Y. Kaneko
DOI: https://doi.org/10.55563/clinexprheumatol/7yv1dz
J. Kikuchi, H. Hanaoka, S. Saito, T. Oshige, K. Hiramoto, T. Takeuchi, Y. Kaneko
DOI: https://doi.org/10.55563/clinexprheumatol/7yv1dz
CER16243
2023,41,7
Pg. 1507-1515
Skin microcirculation dynamics are impaired in patients with rheumatoid arthritis and no cardiovascular comorbidities
P. Anyfanti, E. Gavriilaki, P. Dolgyras, B. Nikolaidou, A. Dimitriadou, A. Lazaridis, K. Mastrogiannis, N. Koletsos, A. Triantafyllou, T. Dimitroulas, S. Aslanidis, M. Doumas, S. Douma, E. Gkaliagkousi
DOI: https://doi.org/10.55563/clinexprheumatol/nf05o4
P. Anyfanti, E. Gavriilaki, P. Dolgyras, B. Nikolaidou, A. Dimitriadou, A. Lazaridis, K. Mastrogiannis, N. Koletsos, A. Triantafyllou, T. Dimitroulas, S. Aslanidis, M. Doumas, S. Douma, E. Gkaliagkousi
DOI: https://doi.org/10.55563/clinexprheumatol/nf05o4
CER16099
2023,41,7
Pg. 1516-1527
Free to view
Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study
W. Yang, Y. Xu, J. Lin, J. Liu, Y. Tan, J. Chen, X. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/h9lvvc
W. Yang, Y. Xu, J. Lin, J. Liu, Y. Tan, J. Chen, X. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/h9lvvc
CER16167
2023,41,7
Pg. 1528-1536
Kihon Checklist validation in patients with rheumatoid arthritis: Italian translation, cross-cultural adaptation, and evaluation of the validity in comparison to two frailty screening tools based on the Fried phenotype and deficit accumulation model
F. Salaffi, S. Farah, M. Di Carlo
DOI: https://doi.org/10.55563/clinexprheumatol/r9ufbo
F. Salaffi, S. Farah, M. Di Carlo
DOI: https://doi.org/10.55563/clinexprheumatol/r9ufbo
CER16208
2023,41,7
Pg. 1537-1543
Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy
C. Almeida-Santiago, J.C. Quevedo-Abeledo, V. Hernández-Hernández, A. De vera-González, A. González-Delgado, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/mr4bka
C. Almeida-Santiago, J.C. Quevedo-Abeledo, V. Hernández-Hernández, A. De vera-González, A. González-Delgado, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/mr4bka
Brief Paper
CER16410
2023,41,7
Pg. 1544-1547
Free to view
Usefulness of methotrexate in relapsing idiopathic retroperitoneal fibrosis
F. Vianello, L. Romano Gargarella, F. Cinetto, R. Scarpa, J. Ceccato, R. Marcolongo
DOI: https://doi.org/10.55563/clinexprheumatol/atxzl5
F. Vianello, L. Romano Gargarella, F. Cinetto, R. Scarpa, J. Ceccato, R. Marcolongo
DOI: https://doi.org/10.55563/clinexprheumatol/atxzl5
Paediatric Rheumatology
CER16251
2023,41,7
Pg. 1548-1552
Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis
L. De Nardi, S. Pastore, F. Rispoli, A. Tesser, A. Pin, A. Taddio, A. Tommasini
DOI: https://doi.org/10.55563/clinexprheumatol/b37xbd
L. De Nardi, S. Pastore, F. Rispoli, A. Tesser, A. Pin, A. Taddio, A. Tommasini
DOI: https://doi.org/10.55563/clinexprheumatol/b37xbd
CER16369
2023,41,7
Pg. 1553-1560
Opioid use in children with inflammatory bowel disease-related arthritis
A.O. Bilgic Dagci, J.C. Chang, R. Xiao, A.B. Grossman, P.F. Weiss
DOI: https://doi.org/10.55563/clinexprheumatol/3bu1sf
A.O. Bilgic Dagci, J.C. Chang, R. Xiao, A.B. Grossman, P.F. Weiss
DOI: https://doi.org/10.55563/clinexprheumatol/3bu1sf
Letters to the Editor
CER16319
2023,41,7
Pg. 1561-1562
Free to view
Usefulness of brain 18Fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of neuropsychiatric systemic lupus erythematosus: a case report
G. Vial, N. Gensous, M. Meyer, P. Duffau
DOI: https://doi.org/10.55563/clinexprheumatol/9kq9gi
G. Vial, N. Gensous, M. Meyer, P. Duffau
DOI: https://doi.org/10.55563/clinexprheumatol/9kq9gi
CER16536
2023,41,7
Pg. 1563-1564
Free to view
Obesity and adipose tissue cytokines in rheumatoid arthritis treated with IL-6 inhibitors: does the route of administration matter?
M. Novella-Navarro, F. Genre, A. Martínez-Feito, V. Pulito-Cueto, C. Plasencia-Rodríguez, A. Balsa
DOI: https://doi.org/10.55563/clinexprheumatol/4u63ht
M. Novella-Navarro, F. Genre, A. Martínez-Feito, V. Pulito-Cueto, C. Plasencia-Rodríguez, A. Balsa
DOI: https://doi.org/10.55563/clinexprheumatol/4u63ht
CER16557
2023,41,7
Pg. 1565
Free to view
Comment on: Alpha-Klotho protein in systemic lupus erythematosus
L. Jiang, Z. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/m6rr26
L. Jiang, Z. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/m6rr26
CER16570
2023,41,7
Pg. 1566
Free to view
Reply to comment on: Alpha-Klotho protein in systemic lupus erythematosus
I. Ferraz-Amaro, M.A. Gonzalez-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/okuim1
I. Ferraz-Amaro, M.A. Gonzalez-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/okuim1